Rationale: Infants and young children might be particularly likely to experience the potential
clinical side effects of inhaled corticosteroids (ICSs) on body mass index (BMI), adiposity …

Background It has been proposed that maternal obesity during pregnancy may increase the
risk that the child develops allergic disease and asthma, although the mechanisms …

Background Infants and young children might be particularly susceptible to the potential side
effects from inhaled corticosteroid (ICS) on height and bone mineral content (BMC), but this …

Objective: Comorbid asthma and obesity leads to poorer asthma outcomes, partially due to
decreased response to controller medication. Increased oral steroid prescription, a marker of …

Background Controversial data exist on the possibility that inhaled corticosteroids (IC s)
affect growth in children with mild‐to‐moderate asthma. We assessed whether IC s affect …

Background The use of inhaled glucocorticoids for persistent asthma causes a temporary
reduction in growth velocity in prepubertal children. The resulting decrease in attained …

OBJECTIVE: Preterm birth is associated with respiratory morbidity later in life, including
asthma. Previous studies have mainly focused on asthma in early childhood in children born …

Inhaled corticosteroids (ICS) are recommended as the first-line therapy for children with
persistent asthma. These agents are particularly effective in reducing underlying airway …

Background Overweight/obesity (OW) is linked to worse asthma and poorer inhaled
corticosteroid (ICS) response in older children and adults. Objective We sought to describe …

This review summarizes the current evidence regarding the effects of inhaled corticosteroids
(ICS) on growth in children with asthma. The evidence from randomized trials showed a …